R-MA regimen

Jump to navigation Jump to search

WikiDoc Resources for R-MA regimen

Articles

Most recent articles on R-MA regimen

Most cited articles on R-MA regimen

Review articles on R-MA regimen

Articles on R-MA regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-MA regimen

Images of R-MA regimen

Photos of R-MA regimen

Podcasts & MP3s on R-MA regimen

Videos on R-MA regimen

Evidence Based Medicine

Cochrane Collaboration on R-MA regimen

Bandolier on R-MA regimen

TRIP on R-MA regimen

Clinical Trials

Ongoing Trials on R-MA regimen at Clinical Trials.gov

Trial results on R-MA regimen

Clinical Trials on R-MA regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-MA regimen

NICE Guidance on R-MA regimen

NHS PRODIGY Guidance

FDA on R-MA regimen

CDC on R-MA regimen

Books

Books on R-MA regimen

News

R-MA regimen in the news

Be alerted to news on R-MA regimen

News trends on R-MA regimen

Commentary

Blogs on R-MA regimen

Definitions

Definitions of R-MA regimen

Patient Resources / Community

Patient resources on R-MA regimen

Discussion groups on R-MA regimen

Patient Handouts on R-MA regimen

Directions to Hospitals Treating R-MA regimen

Risk calculators and risk factors for R-MA regimen

Healthcare Provider Resources

Symptoms of R-MA regimen

Causes & Risk Factors for R-MA regimen

Diagnostic studies for R-MA regimen

Treatment of R-MA regimen

Continuing Medical Education (CME)

CME Programs on R-MA regimen

International

R-MA regimen en Espanol

R-MA regimen en Francais

Business

R-MA regimen in the Marketplace

Patents on R-MA regimen

Experimental / Informatics

List of terms related to R-MA regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Methotrexate-Cytarabine (Ara C) regimen

Overview

R-MA regimen refers to a regimen consisting of rituximab, methotrexate, and cytarabine (Ara C) used to treat mantle cell lymphoma.[1]

Regimen

RRituximab

MMethotrexate

ACytarabine (Ara-C)

Indications

References

  1. 1.0 1.1 Bernstein SH, Epner E, Unger JM, Leblanc M, Cebula E, Burack R; et al. (2013). "A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213". Ann Oncol. 24 (6): 1587–93. doi:10.1093/annonc/mdt070. PMC 3660082. PMID 23504948.